567 related articles for article (PubMed ID: 30473694)
1. Review of the Amphibian Immune Response to Chytridiomycosis, and Future Directions.
Grogan LF; Robert J; Berger L; Skerratt LF; Scheele BC; Castley JG; Newell DA; McCallum HI
Front Immunol; 2018; 9():2536. PubMed ID: 30473694
[TBL] [Abstract][Full Text] [Related]
2. Amphibian immune defenses against chytridiomycosis: impacts of changing environments.
Rollins-Smith LA; Ramsey JP; Pask JD; Reinert LK; Woodhams DC
Integr Comp Biol; 2011 Oct; 51(4):552-62. PubMed ID: 21816807
[TBL] [Abstract][Full Text] [Related]
3. Fighting a losing battle: vigorous immune response countered by pathogen suppression of host defenses in the chytridiomycosis-susceptible frog Atelopus zeteki.
Ellison AR; Savage AE; DiRenzo GV; Langhammer P; Lips KR; Zamudio KR
G3 (Bethesda); 2014 May; 4(7):1275-89. PubMed ID: 24841130
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex variation and the evolution of resistance to amphibian chytridiomycosis.
Fu M; Waldman B
Immunogenetics; 2017 Aug; 69(8-9):529-536. PubMed ID: 28695290
[TBL] [Abstract][Full Text] [Related]
5. The amphibian complement system and chytridiomycosis.
Rodriguez KM; Voyles J
J Exp Zool A Ecol Integr Physiol; 2020 Dec; 333(10):706-719. PubMed ID: 33052039
[TBL] [Abstract][Full Text] [Related]
6. Immunological Aspects of Chytridiomycosis.
Grogan LF; Humphries JE; Robert J; Lanctôt CM; Nock CJ; Newell DA; McCallum HI
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33086692
[TBL] [Abstract][Full Text] [Related]
7. Amphibian chytridiomycosis: a review with focus on fungus-host interactions.
Van Rooij P; Martel A; Haesebrouck F; Pasmans F
Vet Res; 2015 Nov; 46():137. PubMed ID: 26607488
[TBL] [Abstract][Full Text] [Related]
8. Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the South African clawed frog, Xenopus laevis.
Ramsey JP; Reinert LK; Harper LK; Woodhams DC; Rollins-Smith LA
Infect Immun; 2010 Sep; 78(9):3981-92. PubMed ID: 20584973
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations.
Rollins-Smith LA; Conlon JM
Dev Comp Immunol; 2005; 29(7):589-98. PubMed ID: 15784290
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of local immune responses by the frog-killing fungus Batrachochytrium dendrobatidis.
Fites JS; Reinert LK; Chappell TM; Rollins-Smith LA
Infect Immun; 2014 Nov; 82(11):4698-706. PubMed ID: 25156734
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Batrachochytrium dendrobatidis and its amphibian hosts: a review of pathogenesis and immunity.
Voyles J; Rosenblum EB; Berger L
Microbes Infect; 2011 Jan; 13(1):25-32. PubMed ID: 20951224
[TBL] [Abstract][Full Text] [Related]
12. Do immune system changes at metamorphosis predict vulnerability to chytridiomycosis? An update.
Humphries JE; Lanctôt CM; Robert J; McCallum HI; Newell DA; Grogan LF
Dev Comp Immunol; 2022 Nov; 136():104510. PubMed ID: 35985564
[TBL] [Abstract][Full Text] [Related]
13. Out in the cold and sick: low temperatures and fungal infections impair a frog's skin defenses.
Robak MJ; Reinert LK; Rollins-Smith LA; Richards-Zawacki CL
J Exp Biol; 2019 Sep; 222(Pt 18):. PubMed ID: 31488625
[TBL] [Abstract][Full Text] [Related]
14. When Defenses Fail: Atelopus zeteki Skin Secretions Increase Growth of the Pathogen Batrachochytrium dendrobatidis.
Gass J; Voyles J
Integr Comp Biol; 2022 Dec; 62(6):1595-1605. PubMed ID: 35640912
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.
Holden WM; Ebert AR; Canning PF; Rollins-Smith LA
Appl Environ Microbiol; 2014 Jul; 80(13):4034-41. PubMed ID: 24771024
[TBL] [Abstract][Full Text] [Related]
16. Predicted disease susceptibility in a Panamanian amphibian assemblage based on skin peptide defenses.
Woodhams DC; Voyles J; Lips KR; Carey C; Rollins-Smith LA
J Wildl Dis; 2006 Apr; 42(2):207-18. PubMed ID: 16870844
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory metabolites released by the frog-killing fungus Batrachochytrium dendrobatidis.
Rollins-Smith LA; Fites JS; Reinert LK; Shiakolas AR; Umile TP; Minbiole KP
Infect Immun; 2015 Dec; 83(12):4565-70. PubMed ID: 26371122
[TBL] [Abstract][Full Text] [Related]
18. Confronting inconsistencies in the amphibian-chytridiomycosis system: implications for disease management.
Venesky MD; Raffel TR; McMahon TA; Rohr JR
Biol Rev Camb Philos Soc; 2014 May; 89(2):477-83. PubMed ID: 24118903
[TBL] [Abstract][Full Text] [Related]
19. Mitigating amphibian chytridiomycosis with bioaugmentation: characteristics of effective probiotics and strategies for their selection and use.
Bletz MC; Loudon AH; Becker MH; Bell SC; Woodhams DC; Minbiole KP; Harris RN
Ecol Lett; 2013 Jun; 16(6):807-20. PubMed ID: 23452227
[TBL] [Abstract][Full Text] [Related]
20. Mountain Yellow-legged Frogs (Rana muscosa) did not Produce Detectable Antibodies in Immunization Experiments with Batrachochytrium dendrobatidis.
Poorten TJ; Stice-Kishiyama MJ; Briggs CJ; Rosenblum EB
J Wildl Dis; 2016 Jan; 52(1):154-8. PubMed ID: 26540180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
